Page 2 - Aboud Group News Today

Share: YAVNE, Israel, Dec. 14, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced it has further expanded its NexoBrid ® global presence and entered the Middle Eastern markets with the signing of a distribution agreement granting Ghassan Aboud Group (GAG), an international conglomerate based in the United Arab Emirates (UAE), an exclusive ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. MediWound Continues Global Expansion with Distribution Agreement for NexoBrid in United Arab ... MediWound Ltd.December 14, 2020 GMT YAVNE, Israel, Dec. 14, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced it has further expanded its NexoBrid® g...

Illustrative image of sliced pineapple (Anusorn Sutapan; iStock by Getty Images) “GAG, through its life sciences arm – Gaelan Medical Trade LLC, has extensive knowledge and experience in treating wounds, and holds substantial relationships with important clinical institutions in the UAE. We believe that together with GAG we can create new opportunities for NexoBrid across the region, providing a new paradigm for burn experts in treating severe burns, which can improve the lives of patients ...

MediWound signs UAE burns treatment distribution deal Under the terms of the agreement, Ghassan Aboud Group will have exclusive rights to market and distribute NexoBrid in the UAE. Israeli burn and wound management biopharmaceutical company MediWound Ltd. (Nasdaq: MDWD) today announced it has signed a distribution agreement with UAE-based international conglomerate Ghassan Aboud Group (GAG) for NexoBrid for the treatment of severe burns. Under the terms of the agreement, GAG will have exclusive...